Wuyts, of University Hospitals Leuven discusses interim FIBRONEER-ON open-label extension data showing nerandomilast's favorable safety profile.
Wim Wuyts, MD, PhD
Advertisement
Professor and Pneumologist, University Hospitals Leuven
Articles by Wim Wuyts, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
FDA Clears Beta Bionics' Mint Insulin Patch Pump for Diabetes
2
How Wildfire Smoke Triggers Allergic Disease Long After It Clears
3
Diabetes Dialogue: Beta Bionics' Mint Patch Pump Gains FDA Clearance
4
FDA Priority Review Granted to Zasocitinib for Moderate to Severe Psoriasis
5